Your browser doesn't support javascript.
loading
X-ray imageable, drug-loaded hydrogel that forms at body temperature for image-guided, needle- based locoregional drug delivery.
Delgado, Jose F; Pritchard, William F; Varble, Nicole; Lopez-Silva, Tania L; Arrichiello, Antonio; Mikhail, Andrew S; Morhard, Robert; Ray, Trisha; Havakuk, Michal M; Nguyen, Alex; Borde, Tabea; Owen, Joshua W; Schneider, Joel P; Karanian, John W; Wood, Bradford J.
Afiliação
  • Delgado JF; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Pritchard WF; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Varble N; Philips (United States).
  • Lopez-Silva TL; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
  • Arrichiello A; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Mikhail AS; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Morhard R; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Ray T; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Havakuk MM; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Nguyen A; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Borde T; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Owen JW; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Schneider JP; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
  • Karanian JW; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
  • Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health.
Res Sq ; 2024 Mar 06.
Article em En | MEDLINE | ID: mdl-38496436
ABSTRACT
Liver cancer ranks as the fifth leading cause of cancer-related death globally. Direct intratumoral injections of anti-cancer therapeutics may improve therapeutic efficacy and mitigate adverse effects compared to intravenous injections. Some challenges of intratumoral injections are that the liquid drug formulation may not remain localized and have unpredictable volumetric distribution. Thus, drug delivery varies widely, highly-dependent upon technique. An x-ray imageable poloxamer 407 (POL)-based drug delivery gel was developed and characterized, enabling real-time feedback. Utilizing three needle devices, POL or a control iodinated contrast solution were injected into an ex vivo bovine liver. The 3D distribution was assessed with cone beam computed tomography (CBCT). The 3D distribution of POL gels demonstrated localized spherical morphologies regardless of the injection rate. In addition, the gel 3D conformal distribution could be intentionally altered, depending on the injection technique. When doxorubicin (DOX) was loaded into the POL and injected, DOX distribution on optical imaging matched iodine distribution on CBCT suggesting spatial alignment of DOX and iodine localization in tissue. The controllability and localized deposition of this formulation may ultimately reduce the dependence on operator technique, reduce systemic side effects, and facilitate reproducibility across treatments, through more predictable standardized delivery.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article